NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,009 filers reported holding NOVARTIS A G in Q1 2018. The put-call ratio across all filers is 0.56 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $1,531,000 | +93.1% | 17,843 | +69.9% | 0.02% | +220.0% |
| Q2 2018 | $793,000 | -42.3% | 10,500 | -38.2% | 0.01% | -44.4% |
| Q1 2018 | $1,374,000 | -40.1% | 16,993 | -45.0% | 0.01% | -50.0% |
| Q1 2017 | $2,295,000 | -70.3% | 30,900 | -65.6% | 0.02% | -74.6% |
| Q4 2015 | $7,726,000 | +567.2% | 89,800 | +612.7% | 0.07% | +491.7% |
| Q3 2015 | $1,158,000 | -28.2% | 12,600 | -23.2% | 0.01% | -25.0% |
| Q2 2015 | $1,613,000 | -31.5% | 16,400 | -31.3% | 0.02% | -27.3% |
| Q1 2015 | $2,354,000 | +34.4% | 23,872 | +26.3% | 0.02% | 0.0% |
| Q4 2014 | $1,751,000 | +89.3% | 18,900 | +92.3% | 0.02% | +57.1% |
| Q3 2014 | $925,000 | -1.2% | 9,827 | -19.5% | 0.01% | 0.0% |
| Q3 2013 | $936,000 | -4.5% | 12,203 | -12.0% | 0.01% | -6.7% |
| Q2 2013 | $980,000 | – | 13,866 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Martin Investment Management, LLC | 229,184 | $23,344,682 | 7.00% |
| Foresight Global Investors, Inc. | 97,500 | $9,397,737 | 5.23% |
| SCHARF INVESTMENTS, LLC | 1,425,745 | $145,226,322 | 4.34% |
| MANAGED ASSET PORTFOLIOS, LLC | 274,204 | $27,930,369 | 4.28% |
| GARLAND CAPITAL MANAGEMENT INC | 54,710 | $5,572,761 | 3.93% |
| PRENTISS SMITH & CO INC | 52,032 | $5,299,980 | 3.91% |
| WILKINS INVESTMENT COUNSEL INC | 130,950 | $13,339 | 3.61% |
| First Fiduciary Investment Counsel, Inc. | 145,731 | $14,844 | 3.48% |
| Cullen Capital Management, LLC | 2,714,809 | $276,530,464 | 3.23% |
| JOHN G ULLMAN & ASSOCIATES INC | 182,690 | $18,608,803 | 3.04% |